Pradaxa and Lung cancer metastatic - from FDA reports


Summary

Lung cancer metastatic is found among people who take Pradaxa, especially for people who are male, 60+ old , have been taking the drug for 1 - 6 months, also take medication Aspirin, and have Stroke. This review analyzes which people have Lung cancer metastatic with Pradaxa. It is created by eHealthMe based on reports of 56,540 people who have side effects when taking Pradaxa from FDA , and is updated regularly.

What to expect?

If you take Pradaxa and have Lung cancer metastatic, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Pradaxa and have Lung cancer metastatic

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 03, 2017

56,540 people reported to have side effects when taking Pradaxa.
Among them, 12 people (0.02%) have Lung cancer metastatic


Number of reports submitted per year:

Could Pradaxa cause Lung cancer metastatic?

Time on Pradaxa when people have Lung cancer metastatic *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Lung cancer metastatic when taking Pradaxa *:

  • female: 25 %
  • male: 75 %

Age of people who have Lung cancer metastatic when taking Pradaxa *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Stroke (5 people, 41.67%)
  • High Blood Pressure (2 people, 16.67%)
  • Gastroesophageal Reflux Disease (2 people, 16.67%)
  • Thrombotic Stroke (1 person, 8.33%)
  • Hyperlipidaemia (1 person, 8.33%)

Top co-used drugs for these people *:

  • Protonix (1 person, 8.33%)
  • Procardia Xl (1 person, 8.33%)
  • Coreg (1 person, 8.33%)
  • Atenolol (1 person, 8.33%)
  • Aspirin (1 person, 8.33%)

Top other side effects for these people *:

  • Nosebleed (2 people, 16.67%)
  • Head Injury (2 people, 16.67%)
  • Fall (2 people, 16.67%)
  • Cerebral Haemorrhage (2 people, 16.67%)
  • Bleeding Disorders (2 people, 16.67%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Lung cancer metastatic when taking Pradaxa?

Expand the study to include all drugs with the same ingredients

Lung cancer metastatic and drugs with ingredients of dabigatran etexilate mesylate.

Expand the study to include reports from both FDA and eHealthMe

Lung cancer metastatic and Pradaxa from FDA and eHealthMe reports

Pradaxa

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. (latest outcomes from Pradaxa 57,251 users)

Lung cancer metastatic

Lung cancer metastatic (lung cancer spreads to other parts) has been reported by people with rheumatoid arthritis, lung neoplasm malignant, multiple sclerosis, schizophrenia, pain (latest reports from 3,492 Lung cancer metastatic patients).

Browse all side effects of Pradaxa

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Lung cancer metastatic

Lung cancer metastatic

Could your condition cause Lung cancer metastatic

Lung cancer metastatic

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Pradaxa and have Lung cancer metastatic.

Questions to the study

More questions >

User reviews to the study

More reviews >